Evidence map›Paper›PMID 23721687›Full record

ReviewJournal of pharmaceutical and biomedical analysis2014

Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.

Dhavalkumar Narendrabhai Patel, Lin Li, Chee-Leong Kee, Xiaowei Ge, Min-Yong Low, Hwee-Ling Koh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of pharmaceutical and biomedical analysis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. A synthetic mimic of phosphodiesterase type 5 based on corona phase molecular recognition of single-walled carbon nanotubes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors.Current therapeutic research, clinical and experimental · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Dhavalkumar Narendrabhai PatelDepartment of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.
Lin Li
Chee-Leong Kee
Xiaowei Ge
Min-Yong Low
Hwee-Ling Koh
Health Sciences Authority · SGNational University of Singapore · SGNational Science Library · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The popularity of phosphodiesterase type 5 (PDE-5) enzyme inhibitors for the treatment of erectile dysfunction has led to the increase in prevalence of illicit sexual performance enhancement products. PDE-5 inhibitors, namely sildenafil, tadalafil and vardenafil, and their unapproved designer analogues are being increasingly used as adulterants in the herbal products and health supplements marketed for sexual performance enhancement. To date, more than 50 unapproved analogues of prescription PDE-5 inhibitors were found as adulterants in the literature. To avoid detection of such adulteration by standard screening protocols, the perpetrators of such illegal products are investing time and resources to synthesize exotic analogues and devise novel means for adulteration. A comprehensive review of conventional and advance analytical techniques to detect and characterize the adulterants is presented. The rapid identification and structural elucidation of unknown analogues as adulterants is greatly enhanced by the wide myriad of analytical techniques employed, including high performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), liquid chromatography mass-spectrometry (LC-MS), nuclear magnetic resonance (NMR) spectroscopy, vibrational spectroscopy, liquid chromatography-Fourier transform ion cyclotron resonance-mass spectrometry (LC-FT-ICR-MS), liquid chromatograph-hybrid triple quadrupole linear ion trap mass spectrometer with information dependent acquisition, ultra high performance liquid chromatography-time of flight-mass spectrometry (UHPLC-TOF-MS), ion mobility spectroscopy (IMS) and immunoassay methods. The many challenges in detecting and characterizing such adulterants, and the need for concerted effort to curb adulteration in order to safe guard public safety and interest are discussed.

Indexed as

CarbolinesChemistry Techniques, AnalyticalDrug ContaminationHumansImidazolesPharmaceutical PreparationsPhosphodiesterase 5 InhibitorsPiperazinesPlant PreparationsPurinesSildenafil CitrateSulfonesTadalafilTriazinesVardenafil DihydrochlorideCarbolinesImidazolesPharmaceutical PreparationsPhosphodiesterase 5 InhibitorsPiperazinesPlant PreparationsPurinesSildenafil CitrateSulfonesTadalafilTriazinesVardenafil Dihydrochloride(13)C NMR1 dimensional nuclear magnetic resonance1D NMR(1)H NMR2 dimensional nuclear magnetic resonance2D NMRAnalytical techniquescapillary electrophoresis–mass spectrometrycarbon-13-nuclear magnetic resonanceCARTCE-MSChallengesCIDclassification and regression treesCNLScollision induced dissociationconstant neutral loss scancorrelation spectroscopyCOSYDADDCBIDEPTDesigner analoguesdesorption corona beam ionizationdiffusion ordered spectroscopy–nuclear magnetic resonancediode array detectordiscriminant partial least squaresdistortionless enhancement by polarization transferDOSY–NMRD-PLSEDelectrospray ionizationerectile dysfunctionESIEUEuropean UnionFourier transformed infraredFourier transformed infrared attenuated total reflectanceFourier transform ion cyclotron resonance-mass spectrometryFT-ICR-MSFT-IRFTIR-ATRgas chromatography–mass spectrometryGC–MSHealth Sciences Authority Singaporeheteronuclear multiple-bond correlation spectroscopyheteronuclear multiple-quantum correlation spectroscopyhigh performance liquid chromatographyhigh performance liquid chromatography-desorption corona beam ionization–tandem mass spectrometryhigh performance thin layer chromatographyhigh resolution mass spectrometryHMBCHMQCHPLCHPLC-DCBI–MS/MSHPTLCHRMSHSAIDAIMSinformation dependent acquisitionion mobility spectroscopyLC–ESI-MS(n)LC–FT-ICR-MSLC–LTQ Orbitrap XL FTMSLC–MSLC–q-TOF-MS/MSLC–TIS-MSLC–TOF-MSliquid chromatography–electrospray ionization-tandem mass spectrometerliquid chromatography-Fourier transform ion cyclotron resonance-mass spectrometryliquid chromatography–linear ion orbitrap XL Fourier transform mass spectrometryliquid chromatography mass-spectrometryliquid chromatography–quadrupole-time-of-flight-tandem mass spectrometryliquid chromatography–time of flight-mass spectrometryliquid chromatography–turbo ion spray mass spectrometrymass spectrometryMDMAmethylenedioxymethamphetamineMRMMSMS/MSMS(n)multiple reaction monitoringmulti-stage mass spectrometryNDAnear infraredNew Drug ApplicationNIRNMRNOENOESYnuclear magnetic resonancenuclear Overhauser effectnuclear Overhauser effect spectroscopyPCAPDE-5PDE-5 inhibitorsphosphodiesterase type 5 enzymePISPPPRECprecursor ion scanningprincipal component analysisproduct ion scanningprojection pursuitproton nuclear magnetic resonanceScreening for adulterantsselected ion monitoringselected reaction monitoringSIMSIMCAsoft independent modelling by class analogySRMsupport vector machinesSVMtandem mass spectrometrythin layer chromatographyTHMPDtime of flightTISTLCTOFTQ-LITTraditional Herbal Medicinal Products Directivetriple quadruple linear ion trapturbo ion sprayUHPLCultra high performance liquid chromatographyultravioletUnited States Food and Drug AdministrationUSFDAUVX-ray diffractionX-ray fluorescenceXRDXRF

Identifiers

PMID23721687
OpenAlexW1974904275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.